Ligand validation:3VL4

IPM: 3-ISOPROPYLMALIC ACID

IPM is a Ligand Of Interest in 3VL4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VL4_IPM_A_401	97%	30%	0.072	0.984	1.26	1.51	1	1	1	0	100%	1
3VKZ_IPM_A_401	100%	27%	0.037	0.99	1.17	1.77	1	4	0	0	100%	1
3WZV_IPM_A_401	100%	27%	0.045	0.986	1.13	1.78	-	3	0	0	100%	1
3WZX_IPM_A_401	100%	35%	0.045	0.986	1.23	1.33	1	1	0	0	100%	1
3VMJ_IPM_A_401	95%	11%	0.08	0.982	1.6	2.61	1	6	0	0	100%	1
3VL6_IPM_A_401	92%	37%	0.085	0.976	1.16	1.33	-	3	0	0	100%	1
3VMK_IPM_A_401	96%	9%	0.065	0.972	2.25	2.2	4	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.